Quotient amends IPO

Transfusion diagnostics company Quotient Ltd. (Penicuik, U.K.) amended its IPO on NASDAQ and now plans to sell 5 million shares at $14-$16. At the $15 midpoint, the company would raise $75 million and be valued at $215.6 million. Quotient filed to raise up to $75 million in the offering last month. UBS; Baird; and Cowen are underwriters. ...